# The Effects of Bethanechol on Glucose Homeostasis

> **NCT01434901** · PHASE1 · COMPLETED · sponsor: **Washington University School of Medicine** · enrollment: 50 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** Placebo
- **DRUG:** Bethanechol (25 mg)
- **DRUG:** Bethanechol (50 mg)
- **DRUG:** Bethanechol (100 mg)

## Key facts

- **NCT ID:** NCT01434901
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08-15
- **Primary completion:** 2014-07-07
- **Final completion:** 2014-07-07
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2018-05-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01434901

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01434901, "The Effects of Bethanechol on Glucose Homeostasis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01434901. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*